Chelonid herpesvirus (ChHV) and mycoplasmal infections cause similar clinical signs in terrestrial tortoises and may be the most important causative agents of rhinitisstomatitis complex, a common disease in captive tortoises worldwide. Currently, diagnosis of ChHV and Mycoplasma spp. infections is most often based on serologic testing. However, serologic results only detect past exposure, and the specificity of these tests can be reduced due to antigenic cross-reactions with other pathogens. Molecular-based techniques could help to define the causative agent and to better manage infected tortoises. Using polymerase chain reaction, we analyzed 63 tortoises (59 spur-thighed tortoise, Testudo graeca; three Greek tortoise, Testudo ibera; and one Russian tortoise, Agryonemys horsfieldii) with clinical signs of rhinitis-stomatitis complex to identify the causative agent. Molecular evidence of ChHV type I (24%), type II (3%), and Mycoplasma agassizii (6%) infections, as well as coinfection of Mycoplasma-ChHV and both types of ChHV, were detected. Both ChHV and M. agassizii are considered pathogenic in captive tortoises and both are a threat to wild populations. However, neither agent was detected from most of the symptomatic tortoises we evaluated, indicating that other agents could be involved in the rhinitis-stomatitis complex.
Rhinitis and stomatitis are commonly observed in captive chelonians worldwide. Tortoises suffer loss of weight and nasal discharge that results in a weakened physical condition and mortality (Martinez-Silvestre and Mateu, 1997) . Disease is highly transmissible because foamy exudate from the external nares provides a significant source of infection for horizontal transmission (Muro et al., 1998; Origgi and Jacobson, 2000) . Viral agents associated with significant pathology include iridovirus (Westhouse et al., 1996; Marschang et al., 1998; Cunningham, 2000) , papilloma-like virus (Jacobson et al., 1982) , poxvirus (Oró s et al., 1998 ) and a picorna-like virus termed virus ''x'' (Marschang and Ruemenapf, 2002) . However, chelonid herpesviruses (ChHV) appear to be significant in respiratory diseases and are associated with high morbidity and mortality in multiple species of tortoises around the world (Marschang and Schneider, 2007) . Previous studies with herpesviruses from European tortoises (Testudo spp.) showed that at least two types of virus exist (Marshang et al., 2001) . Johnson et al. (2005) described another from a California desert tortoise (Gopherus agassizii). It has been suggested that distinct herpesviruses are adapted to different species of tortoises, and Testudo spp. seem to be the most vulnerable (Origgi and Jacobson, 2000) . Bacteria have also been suggested to play a role in respiratory disease in tortoises (Biberstein and Fowler, 1980; Snipes and Biberstein, 1982; Lawrence and Needham, 1985) , although these have also been recovered from apparently healthy tortoises (Martinez-Silvestre and Mateu, 1997) . Mycoplasma agassizii has been identified and demonstrated to be a causative agent of upper respiratory tract disease in tortoises (Brown et al., 1994; 1999) .
Because clinical signs of herpesviruses overlap with those of mycoplasmosis, identification of the causative agent can be challenging. Currently, diagnosis of ChHV and Mycoplasma infections are based mostly on serologic tests. Diagnosis by antibody detection depends upon tortoise species, virus or bacterial serotype, and the amount of time elapsed since infection (Marshang et al., 2003) . Although both ChHV types differ in sequence, they have similar antigenic sites and cross-reactivity could occur (Johnson et al., 2005) . Repeated tests are frequently necessary, as ChHV antibody titers vary over time and can drop below measurable levels (Marshang et al., 2003 They included seven tongues from tortoises that died before the study (tissues without lesions) and 56 oral swabs collected from live tortoises. We also collected blood samples from 10 of the animals by jugular venipuncture. These samples were processed for PCR simultaneously with swab samples in order to compare both tissues. We used tissue from a clinical tortoise previously found positive by PCR for M. agassizii (provided by Dr. Kerstin Erles, Royal Veterinary College, University of London, London, UK) and a paraffinembedded tissue with confirmed herpesvirus infection (provided by Dr. Antonio Ramis, Universitat Autonò ma de Barcelona, Barcelona, Spain) as PCR-positive controls.
DNA was extracted from swabs using the DNA Extract Quick Kit according to manufacturer's instructions (Epicentre Biotechnologies, Madison, Wisconsin, USA). DNA from tongues was recovered using the protocol described for paraffin tissues (Mü ller et al. 2003) , and DNA from blood was obtained using a general salting-out precipitation (Sambrook et al., 1989) . The eukaryotic 18S RNA Predeveloped TaqMan Assay Reagent (Applied Biosystems, Foster City, California, USA) was used as the internal reference for tortoise genomic DNA amplification to ensure suitability of each sample for PCR amplification and to ensure that negative results corresponded to true negative samples rather than to problems associated with DNA loading, sample degradation, or PCR inhibition. The ChHV and M. agassizii amplifications were carried out as described (VanDevanter et al., 1996 and Brown et al., 1995, respectively) . PCR products were purified from agarose gel using QIAquick gel Extraction kit (Qiagen, Dü sseldorf, Germany) and sequenced using the BigDye TM Terminator Cycle Sequencing Ready Reaction Kit, version 3.1 (Applied Biosystems). Sequencing reactions were purified using the Montage SEQ96 Sequencing Reaction Cleanup Kit (MILIPORE, Billerica, Massachusetts, USA), following manufacturer's instructions, and analyzed in a DNA sequencer ABI PRISM 3730 (Applied Biosystems). Sequences obtained were compared with the sequences of the GenBank database to assign species (http://www.ncbi.nlm.nih. gov/BLAST). To identify the type of ChHV, 8 ml of ChHV PCR were digested with 5 U of BtgI and Hpy188I restriction enzymes in buffer 4 (New England Biolabs, Inc., Ipswich, Massachusetts, USA) in a final volume of 25 ml for 30 min. ChHV type I generates 102/58/ (33/32/9) bp fragments while ChHV type II generates 169/65 bp fragments. The proposed methodology using restriction enzymes can be useful to detect type I, type II, and mixed infections of ChHV without sequencing (Figs. 1, 2) .
All samples (n563) were suitable for PCR amplification based on an 18S RNA amplification TaqMan Assay. From the analysis of these samples, 18 tortoises were positive: 16 were positive for ChHV (25%) and four for M. agassizii (6%). Two tortoises were coinfected with M. agassizii and ChHV (3%; Fig. 1 ). Sixteen positive samples for ChHV were identified as either ChHV type I (15) or ChHV type II (2). One sample contained sequences from both types (Fig. 1) . Seroconversion of tortoises to both types of ChHV (I and II) has been demonstrated 4 wk following infection (Origgi et al., 2001 ) but coinfection had not been previously described. Interspecific coinfection (M. agassiziiChHV) was described by Soares et al. (2004) but the type of ChHV was not identified. Our results showed coinfection of M. agassizii-ChHV in two tortoises with either type I or type II ChHV.
Prevalence was higher for ChHV than for M. agassizii (25% vs. 6%) in contrast to previous molecular-based studies in Testudo spp. Using oral swabs, Soares et al. (2004) found a prevalence of 8.2% and 15.8% for ChHV and M. agassizii respectively (146 captive tortoises from the United Kingdom), and Mathes et al. (2001) found a prevalence of 0.3% and 2.4% respectively (329 tortoises from France and Morocco). The higher prevalence of ChHV in our study could be explained by the different health status (clinical signs) and origin of tortoises (captive vs. wild). All tortoises in our study were clinically affected, while only 35% of tortoises from the United Kingdom showed clinical signs of rhinitis-stomatitis. Additionally, 40% of samples from France and Morocco were collected from the wild. Despite reports of M. agassizii in free-living individuals Feldman et al., 2006) , there are only anecdotal reports of ChHV from wild tortoises (Origgi et al., 2001; Marschang and Schneider, 2007) . These results suggest that M. agassizii could be more frequent in wild and asymptomatic tortoises, while ChHV may be associated more frequently with disease in captive tortoises. It is possible that both pathogens could work synergistically in natural in- fections, thereby causing more severe clinical symptoms or predisposing to infections. Mycoplasmosis, as a chronic infection, lowers the immune response and allows opportunistic organisms to invade or activate viral infection later on, because certain chelonian species act as reservoirs (Mü ller et al., 1990; Muro et al., 1998; Hervás et al. 2002; Soares et al., 2004; Pasmans et al., 2008) .
Isolates of M. agassizii can be difficult to obtain from swabs, as this pathogen colonizes the ventrolateral depressions in the upper respiratory tract (Brown et al., 1999) . With ChHV, we tested 10 animals from which blood and oral swabs were available; there were six positive samples from swabs (60%) while only one blood sample was positive (10%), indicating viremia in at least one animal. These results and the marked tropism of both pathogens for epithelial tissue corroborate the use of oral swab as the most suitable sample for routine diagnosis of both M. agassizii and herpesviruses simultaneously. Neither agent was detected in tongue samples.
Both ChHV and M. agassizii infections have been implicated in the rhinitisstomatitis complex in captive tortoises in Spain. In addition, M. agassizii has been involved in the decline of wild tortoise populations (Brown et al., 1994) . Although ChHV outbreaks have been documented only in captive tortoises, this pathogen could potentially emerge in wild populations (Origgi et al., 2001; Marschang and Schneider, 2007) . Captive and wild populations are connected by the popularity of tortoises as pets (Pé rez et al., 2004) and the collection and release of wild individuals is a frequent practice, mostly in the Mediterranean basin (Ló pez-Jurado et al., 1979; Curl et al., 1985; Fritts and Jennings, 1994; Waller, 1997; Pujol, 1998; Gimé nez et al., 2004; Pé rez et al., 2004) . Understanding the epidemiology of these diseases is pivotal to designing strategies to control and prevent new infections. Despite the fact that all tortoises involved in this study had clinical signs of disease, neither ChHV nor M. agassizii were detected in the majority (68%) of these tortoises, suggesting that other pathognes may be involved in the rhinitis-stomatitis complex.
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